Liu Ting, He Mai, Carlson Diane L, Hedvat Cyrus, Teruya-Feldstein Julie
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Int J Surg Pathol. 2010 Oct;18(5):424-8. doi: 10.1177/1066896908324259. Epub 2008 Sep 14.
This article reports the case of a 59-year-old patient with an 8-year history of chronic lymphocytic leukemia (CLL), prostate carcinoma, and squamous cell carcinoma who developed an ALK-positive anaplastic large cell lymphoma (ALCL). Lymph node and bone marrow biopsies showed 2 distinct morphologic populations: (a) the CLL component showing a diffuse monomorphous infiltrate of small lymphocytes with the typical immunophenotype showing positive CD20, CD5, CD23, and κ light chain restriction and (b) the ALCL component showing large anaplastic pleomorphic cells positive for CD30, CD45, ALK, CD45Ro, CD4, and vimentin. Polymerase chain reaction performed on the lymph node for immunoglobulin heavy chain and T-cell receptor γ and β showed gene rearrangements after macrodissection of morphologically distinct populations, indicating confirmed genetically distinct populations. Despite intensive chemotherapy, the patient died. This case represents the rare occurrence of an ALK-positive ALCL developing in a patient with CLL.
本文报道了一例59岁患者,该患者有8年慢性淋巴细胞白血病(CLL)、前列腺癌和鳞状细胞癌病史,后发生ALK阳性间变性大细胞淋巴瘤(ALCL)。淋巴结和骨髓活检显示出两种不同的形态学细胞群:(a)CLL成分表现为小淋巴细胞弥漫性单形浸润,具有典型免疫表型,CD20、CD5、CD23阳性及κ轻链限制性表达;(b)ALCL成分表现为大的间变性多形细胞,CD30、CD45、ALK、CD45Ro、CD4和波形蛋白阳性。对淋巴结进行免疫球蛋白重链以及T细胞受体γ和β的聚合酶链反应,在对形态学不同的细胞群进行宏观解剖后显示基因重排,表明存在经证实的基因不同的细胞群。尽管进行了强化化疗,患者仍死亡。该病例代表了CLL患者中罕见发生的ALK阳性ALCL。